107. Juvenile idiopathic arthritis Clinical trials / Disease details
Clinical trials : 447 / Drugs : 297 - (DrugBank : 57) / Drug target genes : 52 - Drug target pathways : 146
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT04687930 (ClinicalTrials.gov) | December 1, 2020 | 19/12/2020 | Genicular Nerve Block in Juvenile Idiopathic Arthritis | Genicular Nerve Block in Juvenile Idiopathic Arthritis | Juvenile Idiopathic Arthritis;Persistent Knee Arthritis;no Intra-articular Injection in the Last 3 Months;no Other Cause for Chronic Kneearthritis | Drug: genicular nerve block;Drug: intra-articular steroid injection | Sohag University | NULL | Completed | N/A | 16 Years | All | 104 | Phase 4 | Egypt |